Refresher Course for Diagnosis and Management of Early-Stage Lung Cancer

Refresher Course for Diagnosis and Management of Early-Stage Lung Cancer is organized by European School of Oncology (ESO) and will be held from Mar 20 - 22, 2025 at Belgrade, Central Serbia, Serbia.

Description:
The aims of this course are to provide a comprehensive understanding of the latest diagnostic and therapeutic approaches in the diagnosis and management of early stage lung cancer.. The course will focus on enhancing multidisciplinary collaboration between respiratory physicians, thoracic surgeons, and oncologists to ensure accurate diagnosis, staging, and individualized treatment plans. By addressing the latest advancements in imaging techniques, biopsy procedures, molecular testing, oncology and surgical management the course will equip participants with the skills needed to accurately assess and treat early-stage lung cancer, ensuring patients receive timely, targeted, and effective interventions.

Furthermore, the course aims to improve the participants' knowledge of surgical and non-surgical treatment options, including minimally invasive techniques, stereotactic body radiotherapy (SBRT), and the role of adjuvant therapies. By integrating case-based learning and evidence-based guidelines, the course will foster a deeper understanding of patient-centered care, highlighting the importance of shared decision-making and long-term follow-up. Ultimately, the program seeks to empower physicians to optimize outcomes in early-stage lung cancer, reduce recurrence rates, and improve patient survival and quality of life.

Learning Objectives:

• Understand the epidemiology and burden of lung cancer in Europe.
• Refresh knowledge on the benefits of lung cancer screening and understand unanswered questions with regards screening programmes.
• Understand the new changes being introduced in TNM 9 staging system.
• Learn about how best to diagnose and stage a patients lung cancer.
• Understand the natural history and management of ground glass opacities in the lung.
• Learn about the latest developments in peri-operative cancer treatment.
• Understand the challenges a clinicians face with the increased use of immunotherapy.
• Learn about the indications and benefits of a segmentectomy rather than a lobectomy for early stage lung cancer.
• Discuss the advantages and disadvantages of different treatment modalities in different stages of lung cancer.
• Refresh knowledge of different follow-up regimes after treatment of early stage lung cancer and review evidence.